Manage Adverse Events
Maintain FDA Compliance Through Effective Collection, Reporting and Analysis of Pre and Post Marketing Drug Safety Information
January 26 – 27, 2006 * Philadelphia, PA
Visit the conference website for more information and to register.
The number of adverse events has been growing rapidly with the increase in clinical trials. Each adverse event can generate vast amounts of data that needs to be interpreted by many different people, which creates room for error within this important process. The Western Institutional Review Board (IRB) reported that 70% of the adverse event reports they receive are identified as not related to the study at hand. Current regulations encourage researchers and sponsors to report all unsuspected, serious or related adverse events. However, due to undereducated participants, unclear and ever changing regulations and confusion from the media there has been trouble associating the reported adverse events with the drug on trial. This unique conference provides case studies to educate attendees on FDA compliant strategies to report adverse events that enable optimal clinical trial and post market performance. For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at firstname.lastname@example.org or visit the conference website.